Recent studies using overexpression of ERβ demonstrated that reintroduction of ERβ into epithelial ovarian cancer cells leads to reduced cell proliferation, improved survival of mice and decreased metastases [21]. The gene discussed is ESR2; the disease is ovarian carcinoma.